March 15, 2022
Written by Ndivhuwo Mukwevho
Article Photo: Freepik
South African women will have to wait before laying their hands on the newly-approved dapivirine vaginal ring (DPV-VR – while the National Department of Health assesses the effectiveness of the HIV prevention device.
Department of Health (DOH) spokesperson, Foster Mohale, explained the reasons for the rollout delay.
“The department will review the clinical indicators and the implementation requirements approved by the South African Health Products Regulatory Authority (SAHPRA). We will assess the ring’s effectiveness, the cost of procurement product, the delivery requirements, and the potential impact on HIV incidence,” said Mohale.
Comments